FDA recall record

Fabalish Inc recall — FDA F-0290-2025

Potential E Coli contamination.

Class Iclassification
F-0290-2025official record ID
Dec 25, 2024report date

Recall record at a glance

Official recordF-0290-2025
CategoryFood Recalls
ClassificationClass I
FDA record statusTerminated
Recalling firmFabalish,
Report dateDec 25, 2024
Recall initiation dateNov 18, 2024
Quantity57 Units
LocationCarlstadt, NJ, United States

Official product description

Fabalish Inc. , Kickin, Carrot Falafel , 10oz , Cardboard tray inside plastic film inside cardboard box, individual units

Why the product was recalled

Potential E Coli contamination.

Distribution information

CA, CO, FL, GA, IL, IN, KS, MA, MT, NE, NH, NY, OH, TN,TX, UT, VA, WA

How to read the classification

FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.